EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Pathophysiological hallmarks in type 2 diabetes heterogeneity (review)

Dipamoy Datta, Raja Kundu, Rajdeep Basu, Partha Chakrabarti iD

Diabetology International · 2025-04 · 16 (2) · 201-222

DOI: 10.1007/s13340-024-00783-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetology International, online erschienen am 19.12.2024. Verfasst von Dipamoy Datta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Computer Education Training Program, NICS Computer, Kolkata, 700032 India. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Council of Scientific and Industrial Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanistic complexity in type 2 diabetes (T2DM) is primarily responsible for the degrees of heterogeneity and development of complications. A complex mode of interactions between different pathophysiological events and diabetogenic environmental factors support for the genesis of diabetes heterogeneity both in phenotypic and clinical contexts. The currently used diabetes classification strategies suffer from several inconsistencies that cannot fully capture the inherent heterogeneity among the diabetes patients. To effectively address this pathobiological and heterogeneity-related issue in diabetes research, the current review proposes nine pathophysiological hallmarks of T2DM that aims to mechanistically explain complexities of diabetes associated pathophysiological events and their underlying features. These pathophysiological hallmarks are pancreatic beta cell dysfunction, insulin sensitivity, insulin resistance, obesity, aging, subclinical inflammation, metabolic dysregulation, prothrombotic state induction and hypertension. Detail knowledge of these pathophysiological hallmarks with their key molecular mediators, influencing factors, clinical biomarkers and clinical assessment methodologies will greatly support precision medicine approaches in diabetes including patient stratification, subtype diagnosis and treatment. Supplementary Information: The online version contains supplementary material available at 10.1007/s13340-024-00783-w.

Schlagwörter

Stichwörter der Autor:innen

Diabetes mellitus type 2 (T2DM)HeterogeneityInflammationInsulin resistancePathophysiological hallmarkPrecision medicine

Autor:innen und Institutionen

  • Computer Education Training Program, NICS Computer, Kolkata, 700032 India.
  • Department of Cell Biology and Physiology, CSIR-Indian Institute of Chemical Biology, 4 Raja SC Mullick Road, Kolkata, 700032 India.
  • Department of Endocrinology, Nil Ratan Sarkar Medical College, Kolkata, 700014 India.

ORCID-Profile: Partha Chakrabarti

Förderung

  • Council of Scientific and Industrial Research, India

Zitieren

APA

Datta, D., Kundu, R., Basu, R., & Chakrabarti, P. (2025). Pathophysiological hallmarks in type 2 diabetes heterogeneity (review). Diabetology International, 16(2), 201-222. https://doi.org/10.1007/s13340-024-00783-w

Vancouver

Datta D, Kundu R, Basu R, Chakrabarti P. Pathophysiological hallmarks in type 2 diabetes heterogeneity (review). Diabetology International. 2025;16(2):201-222. doi:10.1007/s13340-024-00783-w

BibTeX
@article{Datta2025,
  author = {Datta, Dipamoy and Kundu, Raja and Basu, Rajdeep and Chakrabarti, Partha},
  title = {Pathophysiological hallmarks in type 2 diabetes heterogeneity (review)},
  journal = {Diabetology International},
  year = {2025},
  volume = {16},
  number = {2},
  pages = {201--222},
  doi = {10.1007/s13340-024-00783-w}
}
Kostenlos starten →